ADAR and thyroid gland carcinoma: In summary, our work confirms ADAR1 as an oncogene in thyroid cancer and offers evidence of its mechanism of action through editing CDK13, which confers stronger tumorigenic properties to cells and delocalizes CDK13 from nuclear speckles, the main hub for splicing factors.